排序方式: 共有11条查询结果,搜索用时 15 毫秒
1.
2.
Dodokhova M. A. Kotieva I. M. Safronenko A. V. Alkhusein-Kulyaginova M. S. Sukhorukova N. V. Kotieva V. M. Kotieva E. M. Starostin S. I. Shpakovsky D. B. Nikitin E. A. Milaeva E. R. 《Bulletin of experimental biology and medicine》2022,173(5):620-622
Bulletin of Experimental Biology and Medicine - We performed a comparative analysis of the pharmacological activity of the hybrid organotin compound... 相似文献
3.
4.
V. N. Yarygin S. Ya. Milaeva K. N. Yarygin S. V. Zhukova L. V. Polezhaev A. M. Aleksandrova I. Z. Rechitskii 《Bulletin of experimental biology and medicine》1988,105(2):265-268
Department of Biology, N. I. Pirogov Second Moscow Medical Institute. Department of Biology, Khar'kov Medical Institute. (Presented by Academician of the Academy of Medical Sciences of the USSR V. N. Smirnov.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 105, No. 2, pp. 224–227, February, 1988. 相似文献
5.
6.
Milaeva ER 《Current topics in medicinal chemistry》2011,11(21):2703-2713
The oxidative stress that is associated with the abnormal level of reactive oxygen species (ROS) is considered to be involved in the carcinogenesis process. The antioxidative defense system in the living organism regulates the toxic impact of ROS and there is strong evidence that the antioxidants prevent carcinogenesis. This review will focus on a novel approach to design synthetic metal-based antioxidants and to study their in vitro, ex vivo and in vivo activities in the cellular oxidation processes that might be involved in promotion of carcinogenesis. The antioxidants are divided into several groups depending on the nature of the ligands used: 2,6-dialkylphenols, flavonoids, polyphenols, peptides, purines, pyridines and their derivatives. Some currently achieved results in testing metal complexes as antioxidants show that they could potentially facilitate the scavenging of excess ROS, and thus restore redox balance in the damaged cells and organs. Therefore there is a strong need of the design of novel potential therapeutic candidates for prevention the oxidative stress-related carcinogenesis based on metal complexes. 相似文献
7.
Xanthopoulou MN Hadjikakou SK Hadjiliadis N Milaeva ER Gracheva JA Tyurin VY Kourkoumelis N Christoforidis KC Metsios AK Karkabounas S Charalabopoulos K 《European journal of medicinal chemistry》2008,43(2):327-335
New organotin(IV) complexes with heterocyclic thioamides 2-mercapto-benzothiazole (Hmbzt), 5-chloro-2-mercapto-benzothiazole (Hcmbzt) and 2-mercapto-benzoxazole (Hmbzo) of formulae [(C(6)H(5))(3)Sn(mbzt)] (1), [(C(6)H(5))(3)Sn(cmbzt)] (3) and [(C(6)H(5))(2)Sn(cmbzt)(2)] (4), together with the already known [(C(6)H(5))(3)Sn(mbzo)] (2), [(n-C(4)H(9))(2)Sn(cmbzt)(2)] (5) and [(CH(3))(2)Sn(cmbzt)(2)] (6) were used to study their influence on the peroxidation of oleic acid. The influence of complexes (3)-(6) upon peroxidation of oleic acid showed that the formation of reactive radicals caused the initiation of the chain radical oxidation of the substrate. The influence of complexes (1)-(6) upon the catalytic peroxidation of linoleic acid by the enzyme lipoxygenase (LOX) was also studied and compared to those of cisplatin. Compounds (1)-(6) were finally tested for in vitro cytotoxicity against leiomyosarcoma cells. 相似文献
8.
9.
10.